Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.
D000970:Antineoplastic Agents / Q000097:blood / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans
D000970:Antineoplastic Agents